Clinical Trial Update: Usability of Levodopa Cyclops™ vs INBRIJA® in Parkinson's Patients

View source ↗

Summary

A completed clinical trial evaluated the usability of Levodopa Cyclops compared with INBRIJA in Parkinson's disease patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• INBRIJA (levodopa inhalation powder)
• Levodopa Cyclops

Snippet

Sponsor: Martini Hospital Groningen | Conditions: Usability | Status: COMPLETED